TrianglePUBLICATIONS · 11134196
Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2001 Jan 1
- First author
- Fosså SD
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Fosså SD
- type
- Author
- name
- Slee PH
- type
- Author
- name
- Brausi M
- type
- Author
- name
- Horenblas S
- type
- Author
- name
- Hall RR
- type
- Author
- name
- Hetherington JW
- type
- Author
- name
- Aaronson N
- type
- Author
- name
- de Prijck L
- type
- Author
- name
- Collette L
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Fosså SD
- type
- Author
- name
- Slee PH
- type
- Author
- name
- Brausi M
- type
- Author
- name
- Horenblas S
- type
- Author
- name
- Hall RR
- type
- Author
- name
- Hetherington JW
- type
- Author
- name
- Aaronson N
- type
- Author
- name
- de Prijck L
- type
- Author
- name
- Collette L
- type
- Author
- bibliography ids
- nci-bib-6b036cdd8d5043ee44aa2b5b
- book metadata
- content sha256
- 601ee1830ab1930566de89d4fbf70f13374c84b73a1fd7cb979e4a5acaeada97
- document type
- citation
- dois
- 10.1200/JCO.2001.19.1.62
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:11134196
- immutable id
- pubmed:11134196@601ee1830ab1930566de89d4fbf70f13374c84b73a1fd7cb979e4a5acaeada97
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 1
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 62-71
- volume
- 19
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 11134196
- provenance
- batch id
- 30d2cd7affbbb92b6784
- provider
- NCBI PubMed ESummary
- record sha256
- 91aed05eadab4e4f7fb83f310d473bb764bb33077318a7ff968748bc5ace2fee
- response sha256
- ae7ed930f8b43c9e34eeae02f278f33f49c15777b81f742392c120eb64949120
- retrieved at
- 2026-09-09T23:45:39.779418+00:00
- publication date
- display
- 2001 Jan 1
- precision
- day
- year
- 2001
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group.
Preserved source evidence · Not medical advice